INTECH Investment Management’s NeoGenomics NEO Stock Holding History

INTECH Investment Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$381K	Sell	26,110 -2,664	-9%	-$25.7K	﹤0.01%	1471
2026 Q1	$214K	Sell	28,774 -15,929	-36%	-$168K	﹤0.01%	1726
2025 Q4	$526K	Sell	44,703 -28,766	-39%	-$310K	﹤0.01%	1491
2025 Q3	$567K	Sell	73,469 -65,754	-47%	-$461K	0.01%	1508
2025 Q2	$1.02M	Sell	139,223 -12,583	-8%	-$102K	0.01%	1183
2025 Q1	$1.44M	Buy	151,806 +24,965	+20%	+$312K	0.01%	965
2024 Q4	$2.09M	Buy	126,841 +79,857	+170%	+$1.24M	0.02%	687
2024 Q3	$693K	Buy	46,984 +16,684	+55%	+$261K	0.01%	1034
2024 Q2	$420K	Buy	+30,300	New	+$430K	0.01%	866

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

INTECH Investment Management's NEO Position: Q2 2026 in Review

INTECH Investment Management reduced its NeoGenomics (NEO) stake by 9.3% in Q2 2026, selling an estimated $25.7K and leaving 26,110 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

INTECH Investment Management first reported a position in NEO in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.09M in Q4 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

INTECH Investment Management held 26,110 shares of NeoGenomics worth $381K as of Q2 2026.
INTECH Investment Management sold 2,664 NeoGenomics shares in Q2 2026, an estimated $25.7K.
NeoGenomics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1471 holding.
INTECH Investment Management first reported a position in NeoGenomics in Q2 2024 and has held it in 9 quarters since.
INTECH Investment Management's NeoGenomics position peaked at $2.09M in Q4 2024.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.